https://www.bioworld.com/rss en-us http://www.bioworld.com/articles/730152 Wed, 08 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730152-new-china-biotech-syneron-chases-macrocycle-frontier Multicolor peptide illustration http://www.bioworld.com/articles/730137 Tue, 07 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730137-south-korea-streamlines-biosimilar-review-clinical-trials Drug vials and syringe http://www.bioworld.com/articles/730134 Tue, 07 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730134-amplia-halts-enrollment-in-phase-ii-pancreatic-cancer-trial Illustration of cancer in the pancreas http://www.bioworld.com/articles/730236 Tue, 07 Apr 2026 11:00:00 -0400 https://www.bioworld.com/articles/730236-sector-tariff-now-more-than-a-threat-for-some-rx-companies Digital globe illustrating pharma trade, tariffs http://www.bioworld.com/articles/730204 Tue, 07 Apr 2026 11:00:00 -0400 https://www.bioworld.com/articles/730204-five-drug-vipor-regimen-shows-promise-in-aggressive-blood-cancer PET scans showing before and after treatment with VIPOR Before (top) and after (bottom) treatment with VIPOR. Full-body and cross-sectional PET scans of a patient show large lymphoma tumors (circled in red) that have disappeared with treatment. Credit: Center for Cancer Research/National Cancer Institute http://www.bioworld.com/articles/730116 Mon, 06 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730116-sector-tariff-now-more-than-a-threat-for-some-rx-companies Digital globe illustrating pharma trade, tariffs http://www.bioworld.com/articles/729983 Wed, 01 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/729983-trade-secret-theft-results-in-loss-of-us-citizenship http://www.bioworld.com/articles/729980 Wed, 01 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/729980-five-drug-vipor-regimen-shows-promise-in-aggressive-blood-cancer PET scans showing before and after treatment with VIPOR Before (top) and after (bottom) treatment with VIPOR. Full-body and cross-sectional PET scans of a patient show large lymphoma tumors (circled in red) that have disappeared with treatment. Credit: Center for Cancer Research/National Cancer Institute http://www.bioworld.com/articles/729978 Wed, 01 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/729978-us-fda-warns-of-liver-injuries-8-deaths-associated-with-tavneos Liver over digital lens background http://www.bioworld.com/articles/730091 Tue, 31 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/730091-lilly-taps-insilico-ai-in-275b-deal-to-expand-pipeline-options Pill in immersive interface http://www.bioworld.com/articles/730090 Tue, 31 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/730090-otsuka-to-acquire-ptsd-drugmaker-transcend-in-12b-deal Brain with handshake and cityscape http://www.bioworld.com/articles/730089 Tue, 31 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/730089-innovents-ibi-302-meets-phase-iii-endpoints-in-neovascular-amd Woman taking Amsler grid eye exam http://www.bioworld.com/articles/730088 Tue, 31 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/730088-china-developed-triple-incretin-enters-global-diabetes-race Illustration of glucose molecules in a bloodstream http://www.bioworld.com/articles/730087 Tue, 31 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/730087-korea-roundup-alteogen-celltrion-lead-biotech-deals Seo Jin-seok of Celltrion (right) with Ko Kwang-pyo of Kobiolabs (left) Seo Jin-seok, CEO, Celltrion (right) with Ko Kwang-pyo, founder and CEO, Kobiolabs (left). http://www.bioworld.com/articles/729969 Tue, 31 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729969-simceres-rademikibart-meets-phase-iii-endpoints-in-atopic-dermatitis Monoclonal antibody illustration http://www.bioworld.com/articles/729968 Tue, 31 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729968-braveheart-finds-phase-ii-positive-for-cardiac-myosin-inhibitor 3D illustration of heart cross section http://www.bioworld.com/articles/729952 Mon, 30 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729952-otsuka-to-acquire-ptsd-drugmaker-transcend-in-12b-deal Brain with handshake and cityscape http://www.bioworld.com/articles/729949 Mon, 30 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729949-lilly-taps-insilico-ai-in-275b-deal-to-expand-pipeline-options Pill in immersive interface http://www.bioworld.com/articles/729906 Thu, 26 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729906-korea-roundup-alteogen-celltrion-lead-biotech-deals Seo Jin-seok of Celltrion (right) with Ko Kwang-pyo of Kobiolabs (left) Seo Jin-seok, CEO, Celltrion (right) with Ko Kwang-pyo, founder and CEO, Kobiolabs (left). http://www.bioworld.com/articles/729901 Thu, 26 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729901-china-developed-triple-incretin-enters-global-diabetes-race Illustration of glucose molecules in a bloodstream http://www.bioworld.com/articles/729841 Wed, 25 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729841-innovents-ibi-302-meets-phase-iii-endpoints-in-neovascular-amd Woman taking Amsler grid eye exam http://www.bioworld.com/articles/729898 Tue, 24 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729898-excalipoint-closes-687m-seed-round-for-cancer-t-cell-engagers Blue-gray dollar sign http://www.bioworld.com/articles/729897 Tue, 24 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729897-imbiologics-crosses-1b-market-cap-with-kosdaq-debut Ha-Gyong-sik, CEO, Imbiologics Imbiologics CEO Ha-Gyong-sik at the company's IPO ceremony. http://www.bioworld.com/articles/729896 Tue, 24 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729896-how-to-grow-a-startup-in-the-ai-era-medtech-spotlight-korea-2026 AI startup art concept http://www.bioworld.com/articles/729895 Tue, 24 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729895-simceres-pd-l1-il-15-bispecific-sees-early-edge-in-bladder-cancer Bladder cancer illustration http://www.bioworld.com/articles/729894 Tue, 24 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729894-australias-r-and-d-reset-puts-biotech-translation-in-focus Light bulb shines next to extinguished ones http://www.bioworld.com/articles/729893 Tue, 24 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729893-kintors-kx-826-meets-phase-iii-endpoints-in-alopecia Alopecia - hair loss http://www.bioworld.com/articles/729830 Tue, 24 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729830-chinas-pharma-rise-rattles-us-policymakers China and U.S. flags http://www.bioworld.com/articles/729829 Tue, 24 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729829-gilead-pens-dual-purpose-2b-ouro-m-and-a-deal-with-galapagos Hands holding gears http://www.bioworld.com/articles/729811 Mon, 23 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729811-how-to-grow-a-startup-in-the-ai-era-medtech-spotlight-korea-2026 AI startup art concept